Strategy
MSTR
MARA Holdings
MARA
NVIDIA
NVDA
Tesla
TSLA
Coinbase
COIN
US Stock MarketDetailed Quotes
MDGL Madrigal Pharmaceuticals
- 341.270
- +5.530+1.65%
Close Feb 28 16:00 ET
- 341.270
- 0.0000.00%
Post 20:01 ET
7.54BMarket Cap-15.58P/E (TTM)
342.265High329.800Low330.38KVolume332.000Open335.740Pre Close111.96MTurnover2.90%Turnover RatioLossP/E (Static)22.08MShares377.46052wk High9.99P/B3.89BFloat Cap189.00052wk Low--Dividend TTM11.40MShs Float415.800Historical High--Div YieldTTM3.71%Amplitude6.600Historical Low338.894Avg Price1Lot Size
About Madrigal Pharmaceuticals Company
Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on March 2000 and is headquartered in West Conshohocken, PA.
Company Profile
SymbolMDGL
Company NameMadrigal Pharmaceuticals
Listing DateFeb 6, 2007
Issue Price12.01
Founded2000
CEOMr. William John (Bill) Sibold
MarketNASDAQ
Employees528
Fiscal Year Ends12-31
Address200 Barr Harbor Drive,Suite 200
CityWest Conshohocken
ProvincePennsylvania
CountryUnited States of America
Zip Code19428
Phone1-267-824-2827
Company Executives
- Name
- Position
- Salary
- William John (Bill) Sibold
- Director, President and Chief Executive Officer
- 32.27M
- Dr. Robert E. Waltermire, PhD
- Chief Pharmaceutical Development Officer
- --
- Mardi C. Dier
- Senior Vice President, Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Rebecca A. Taub,M.D.
- Director, Chief Medical Officer and President, Research and Development
- 6.93M
- Carole Huntsman
- Chief Commercial Officer
- 3.14M
- Julian C. Baker
- Chairman of the Board
- 646.00K
- Dr. Paul A. Friedman,M.D.
- Director
- 10.63K
- Dr. Frederick B. Craves, PhD
- Lead Independent Director
- 371.13K
- Dr. Richard S. Levy,M.D.
- Independent Director
- 368.63K
- James M. Daly
- Independent Director
- 363.63K
- Kenneth M. Bate
- Independent Director
- 383.63K
- Dr. Raymond Cheong, M.D.
- Independent Director
- 639.75K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.